Editorial: Impact of Aduhelm Approval on Care and Policy

J Prev Alzheimers Dis. 2021;8(4):396-397. doi: 10.14283/jpad.2021.42.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Approval*
  • Health Policy*
  • Health Services Accessibility
  • Humans
  • Patient Care*

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab